Teladoc Health, Inc. provided earnings guidance for the third quarter and full year of 2022. For the quarter, the company expects revenue of $600 - $620 million. Net loss per share of $0.85 to $0.60.

For the year, the company expects revenue of $2,400 - $2,500 million. Net loss per share of $62.00 - $61.00.